Immunization Newsbriefs (c) Copyright Information Inc., Bethesda, MD. Brought to you by the National Network for Immunization Information (NNii). Visit NNii's new website at http://www.immunizationinfo.org.

------------------------------------------------------------

May 02, 2003

INTERNATIONAL IMMUNIZATION NEWS

"EuroVacc to Test Combination AIDS Vaccine in June"

Reuters Health Information Services (www.reutershealth.com) (04/30/03); Fleck, Fiona

DNA-C, developed by University of Regensburg, Germany, professor Hans Wolf, and its booster NYVAC, developed by Aventis, will be tested for safety as HIV vaccines in Switzerland and the United Kingdom this summer.  The study will involve 160 healthy volunteers, some of whom will receive DNA-C and some of whom will receive NYVAC, while another safety trial in 2004 will give healthy volunteers both vaccines.  DNA-C works by introducing DNA codes from HIV into the body in order to produce antibodies, according to Dr. Jean-Pierre Kraehenbuhl of the EuroVacc Foundation, which is organizing the trials.

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.